Canada markets open in 3 hours 46 minutes

Immunovant, Inc. (IMVT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
15.39+1.88 (+13.92%)
At close: 4:00PM EST

15.06 -0.33 (-2.14%)
Pre-Market: 5:27AM EST

Currency in USD

Valuation Measures

Market Cap (intraday) 51.51B
Enterprise Value 3905.11M
Trailing P/E N/A
Forward P/E 1-10.76
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-9.30

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-10.29%
S&P500 52-Week Change 333.30%
52 Week High 353.75
52 Week Low 38.34
50-Day Moving Average 325.93
200-Day Moving Average 339.11

Share Statistics

Avg Vol (3 month) 31.28M
Avg Vol (10 day) 32.03M
Shares Outstanding 597.97M
Float 33.5M
% Held by Insiders 160.45%
% Held by Institutions 140.74%
Shares Short (Feb. 11, 2021) 43.38M
Short Ratio (Feb. 11, 2021) 42.37
Short % of Float (Feb. 11, 2021) 46.67%
Short % of Shares Outstanding (Feb. 11, 2021) 43.46%
Shares Short (prior month Jan. 14, 2021) 42.55M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar. 30, 2020
Most Recent Quarter (mrq)Dec. 30, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-21.75%
Return on Equity (ttm)-37.96%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -97.33M
Net Income Avi to Common (ttm)-99.82M
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)421.97M
Total Cash Per Share (mrq)4.31
Total Debt (mrq)3.5M
Total Debt/Equity (mrq)0.84
Current Ratio (mrq)26.05
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)-83.88M
Levered Free Cash Flow (ttm)-46.65M